Selective enhancement of the type 1 cytokine response by expression of a canine interleukin (IL)-12 fused heterodimeric DNA

Omar A. Saldarriaga, Luis E. Perez, Bruno Travi, Peter Melby

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Interleukin-12 (IL-12) is a heterodimeric cytokine that is a principal mediator of the innate immune response and modulator of acquired cell-mediated immunity. Administration of exogenous IL-12 can direct the host adaptive T cell response toward a type 1 phenotype. The co-administration of IL-12 with vaccine antigens has been shown to augment the vaccine-induced TH1 response and protection against intracellular pathogens. We show here that a canine IL-12 DNA, constructed by fusing the p35 and p40 subunit cDNAs with an interspacing linker, generated stable IL-12 transcripts when placed under control of a strong constitutive promoter. The protein expressed from this fused cDNA was fully functional in promoting a type 1 (IFN-γ) and suppressing a type 2 (IL-4) cytokine response following both in vitro transfection of a canine cell line and in vivo delivery to dogs. This DNA construct may be useful as an adjuvant for vaccines that target tumors or intracellular pathogens of the dog.

Original languageEnglish (US)
Pages (from-to)377-388
Number of pages12
JournalVeterinary Immunology and Immunopathology
Volume110
Issue number3-4
DOIs
StatePublished - Apr 15 2006
Externally publishedYes

Fingerprint

interleukin-12
Interleukin-12
Canidae
cytokines
Cytokines
dogs
DNA
Vaccines
Complementary DNA
Dogs
vaccines
vaccine adjuvants
Cancer Vaccines
pathogens
Adaptive Immunity
transfection
interleukin-4
Innate Immunity
Cellular Immunity
Interleukin-4

Keywords

  • Canine
  • IFN-γ
  • Interleukin-12
  • Vaccine adjuvant

ASJC Scopus subject areas

  • Animal Science and Zoology
  • Immunology
  • veterinary(all)

Cite this

Selective enhancement of the type 1 cytokine response by expression of a canine interleukin (IL)-12 fused heterodimeric DNA. / Saldarriaga, Omar A.; Perez, Luis E.; Travi, Bruno; Melby, Peter.

In: Veterinary Immunology and Immunopathology, Vol. 110, No. 3-4, 15.04.2006, p. 377-388.

Research output: Contribution to journalArticle

@article{2a19f203686e4d0daba18b9608336499,
title = "Selective enhancement of the type 1 cytokine response by expression of a canine interleukin (IL)-12 fused heterodimeric DNA",
abstract = "Interleukin-12 (IL-12) is a heterodimeric cytokine that is a principal mediator of the innate immune response and modulator of acquired cell-mediated immunity. Administration of exogenous IL-12 can direct the host adaptive T cell response toward a type 1 phenotype. The co-administration of IL-12 with vaccine antigens has been shown to augment the vaccine-induced TH1 response and protection against intracellular pathogens. We show here that a canine IL-12 DNA, constructed by fusing the p35 and p40 subunit cDNAs with an interspacing linker, generated stable IL-12 transcripts when placed under control of a strong constitutive promoter. The protein expressed from this fused cDNA was fully functional in promoting a type 1 (IFN-γ) and suppressing a type 2 (IL-4) cytokine response following both in vitro transfection of a canine cell line and in vivo delivery to dogs. This DNA construct may be useful as an adjuvant for vaccines that target tumors or intracellular pathogens of the dog.",
keywords = "Canine, IFN-γ, Interleukin-12, Vaccine adjuvant",
author = "Saldarriaga, {Omar A.} and Perez, {Luis E.} and Bruno Travi and Peter Melby",
year = "2006",
month = "4",
day = "15",
doi = "10.1016/j.vetimm.2005.11.003",
language = "English (US)",
volume = "110",
pages = "377--388",
journal = "Veterinary Immunology and Immunopathology",
issn = "0165-2427",
publisher = "Elsevier",
number = "3-4",

}

TY - JOUR

T1 - Selective enhancement of the type 1 cytokine response by expression of a canine interleukin (IL)-12 fused heterodimeric DNA

AU - Saldarriaga, Omar A.

AU - Perez, Luis E.

AU - Travi, Bruno

AU - Melby, Peter

PY - 2006/4/15

Y1 - 2006/4/15

N2 - Interleukin-12 (IL-12) is a heterodimeric cytokine that is a principal mediator of the innate immune response and modulator of acquired cell-mediated immunity. Administration of exogenous IL-12 can direct the host adaptive T cell response toward a type 1 phenotype. The co-administration of IL-12 with vaccine antigens has been shown to augment the vaccine-induced TH1 response and protection against intracellular pathogens. We show here that a canine IL-12 DNA, constructed by fusing the p35 and p40 subunit cDNAs with an interspacing linker, generated stable IL-12 transcripts when placed under control of a strong constitutive promoter. The protein expressed from this fused cDNA was fully functional in promoting a type 1 (IFN-γ) and suppressing a type 2 (IL-4) cytokine response following both in vitro transfection of a canine cell line and in vivo delivery to dogs. This DNA construct may be useful as an adjuvant for vaccines that target tumors or intracellular pathogens of the dog.

AB - Interleukin-12 (IL-12) is a heterodimeric cytokine that is a principal mediator of the innate immune response and modulator of acquired cell-mediated immunity. Administration of exogenous IL-12 can direct the host adaptive T cell response toward a type 1 phenotype. The co-administration of IL-12 with vaccine antigens has been shown to augment the vaccine-induced TH1 response and protection against intracellular pathogens. We show here that a canine IL-12 DNA, constructed by fusing the p35 and p40 subunit cDNAs with an interspacing linker, generated stable IL-12 transcripts when placed under control of a strong constitutive promoter. The protein expressed from this fused cDNA was fully functional in promoting a type 1 (IFN-γ) and suppressing a type 2 (IL-4) cytokine response following both in vitro transfection of a canine cell line and in vivo delivery to dogs. This DNA construct may be useful as an adjuvant for vaccines that target tumors or intracellular pathogens of the dog.

KW - Canine

KW - IFN-γ

KW - Interleukin-12

KW - Vaccine adjuvant

UR - http://www.scopus.com/inward/record.url?scp=33644560300&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644560300&partnerID=8YFLogxK

U2 - 10.1016/j.vetimm.2005.11.003

DO - 10.1016/j.vetimm.2005.11.003

M3 - Article

VL - 110

SP - 377

EP - 388

JO - Veterinary Immunology and Immunopathology

JF - Veterinary Immunology and Immunopathology

SN - 0165-2427

IS - 3-4

ER -